Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August

Seeking AlphaOct 4 14:02 ET

12 Health Care Stocks Moving In Wednesday's Intraday Session

BenzingaOct 2 12:31 ET

RAPT Therapeutics, Inc. (RAPT) Stock Falls Following FDA Setback; Short Sellers Cite Unprofitability

Yahoo FinanceSep 25 11:34 ET

Rapt Therapeutics Is Maintained at Neutral by UBS

Dow JonesSep 9 10:33 ET · Ratings

UBS Maintains RAPT Therapeutics(RAPT.US) With Hold Rating, Cuts Target Price to $2

Moomoo NewsSep 6 20:31 ET · Ratings

Express News | RAPT Therapeutics Inc : UBS Cuts Target Price to $2 From $10

ReutersSep 6 09:41 ET